Evolving biosimilar landscape

A meaningful impact on patient care

Biologic medicines, including biosimilars, come in different forms, such as monoclonal antibodies and growth factors. Their capacity to precisely target signaling pathways and cells is revolutionizing the battle against challenging disease areas, including cancer and inflammation.

Biologics have been used successfully to treat many different
life-threatening and chronic diseases